NO983719D0 - Neovaskularisasjonsinhibitor - Google Patents

Neovaskularisasjonsinhibitor

Info

Publication number
NO983719D0
NO983719D0 NO983719A NO983719A NO983719D0 NO 983719 D0 NO983719 D0 NO 983719D0 NO 983719 A NO983719 A NO 983719A NO 983719 A NO983719 A NO 983719A NO 983719 D0 NO983719 D0 NO 983719D0
Authority
NO
Norway
Prior art keywords
neovaskularisasjonsinhibitor
Prior art date
Application number
NO983719A
Other languages
English (en)
Other versions
NO983719L (no
Inventor
Masayuki Isaji
Hiroshi Miyata
Yukiyoshi Ajisawa
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of NO983719D0 publication Critical patent/NO983719D0/no
Publication of NO983719L publication Critical patent/NO983719L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO983719A 1996-02-15 1998-08-13 Neovaskularisasjonsinhibitor NO983719L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6509496 1996-02-15
PCT/JP1997/000354 WO1997029744A1 (fr) 1996-02-15 1997-02-12 Inhibiteur de la neoformation de vaisseaux sanguins

Publications (2)

Publication Number Publication Date
NO983719D0 true NO983719D0 (no) 1998-08-13
NO983719L NO983719L (no) 1998-10-14

Family

ID=13277001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983719A NO983719L (no) 1996-02-15 1998-08-13 Neovaskularisasjonsinhibitor

Country Status (11)

Country Link
US (1) US6407139B1 (no)
EP (1) EP0894496A4 (no)
KR (1) KR19990082523A (no)
CN (1) CN1211182A (no)
BR (1) BR9707514A (no)
CA (1) CA2246418A1 (no)
CZ (1) CZ258598A3 (no)
EA (1) EA199800721A1 (no)
NO (1) NO983719L (no)
NZ (1) NZ331339A (no)
WO (1) WO1997029744A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998013038A1 (fr) * 1996-09-28 1998-04-02 Kissei Pharmaceutical Co., Ltd. Inhibiteur de turbidite sous-epitheliale
EP0958815A4 (en) * 1996-10-14 2001-02-07 Kissei Pharmaceutical SECONDARY CATARACT INHIBITORS
EP1008347A4 (en) * 1997-04-18 2002-02-06 Kissei Pharmaceutical REMEDIES FOR PROPHYLAXIS OR TREATMENT OF DISEASES RESULTING IN EXCESSIVE PROLIFERATION OF PIGMENTAL RETINE EPITHELIAL CELLS
KR20020013942A (ko) 1999-07-01 2002-02-21 우에하라 아끼라 아미노벤조산 유도체
AU7446600A (en) * 1999-10-01 2001-05-10 Japan Energy Corporation Novel diarylamide derivatives and use thereof as medicines
US7531575B2 (en) * 2002-10-31 2009-05-12 Eberhard-Karls-Universität Tübingin Method of modulating cellular activity and agents useful for same
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention
EP1824469A4 (en) * 2004-11-17 2008-07-30 Nuon Therapeutics Pty Ltd METHOD FOR MODULATING B-CELL FUNCTION
US20080009519A1 (en) * 2004-11-17 2008-01-10 Lawrence Steinman Method of modulating t cell functioning
BRPI0610349A2 (pt) * 2005-05-16 2010-06-15 Angiogen Pharmaceuticals Pty L processos e composições para o tratamento de dor
PL2035369T3 (pl) 2006-07-05 2015-02-27 Fibrotech Therapeutics Pty Ltd Związki terapeutyczne
JP2008247789A (ja) * 2007-03-30 2008-10-16 Kissei Pharmaceut Co Ltd クローン病に伴う腸管狭窄の進展抑制用医薬組成物
US20090143388A1 (en) * 2007-08-29 2009-06-04 Mohanakumar Kochupurackal Para Treatment of brain disorders
JP5730578B2 (ja) 2007-12-21 2015-06-10 フィブロテック セラピューティクス プロプライエタリー リミテッド 抗線維症剤のハロゲン化類似体
JP2011006406A (ja) * 2009-05-29 2011-01-13 Santen Pharmaceut Co Ltd トラニラストを含有する網膜疾患の予防または治療剤
US9592213B2 (en) 2009-06-17 2017-03-14 National University Corporation Kumamoto University Prophylactic and/or therapeutic agent for dysmenorrhea
CN105153188B (zh) 2009-10-22 2018-06-01 法博太科制药有限公司 抗纤维化剂的稠环类似物
ES2829620T3 (es) * 2010-11-24 2021-06-01 Occurx Pty Ltd Procedimientos de tratamiento de enfermedades oculares asociadas con inflamación y proliferación vascular
CN102657647A (zh) * 2012-04-06 2012-09-12 澳门大学 Ic-4在抗血管新生中的应用
MX2019009235A (es) 2017-02-03 2019-12-11 Certa Therapeutics Pty Ltd Compuestos antifibroticos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05163222A (ja) * 1991-12-18 1993-06-29 Kissei Pharmaceut Co Ltd コラーゲン過剰合成疾患治療剤
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
US5512591A (en) 1993-02-18 1996-04-30 President And Fellows Of Harvard College Treatments for diseases characterized by neovascularization
EP1181904B1 (en) * 1994-10-17 2009-06-24 Kabushikikaisha Igaki Iryo Sekkei Stent for liberating drug
DE59606488D1 (de) * 1995-08-31 2001-04-05 Infineon Technologies Ag Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
ES2151464T3 (es) * 1996-02-07 2002-12-16 Lead Chem Co Ltd Preparacion para aplicacion externa que comprende tranilast y procedimiento para producirla.

Also Published As

Publication number Publication date
EA199800721A1 (ru) 1999-02-25
BR9707514A (pt) 1999-07-27
NZ331339A (en) 2001-02-23
EP0894496A1 (en) 1999-02-03
CN1211182A (zh) 1999-03-17
KR19990082523A (ko) 1999-11-25
CA2246418A1 (en) 1997-08-21
WO1997029744A1 (fr) 1997-08-21
NO983719L (no) 1998-10-14
US6407139B1 (en) 2002-06-18
CZ258598A3 (cs) 1998-11-11
EP0894496A4 (en) 2001-01-03

Similar Documents

Publication Publication Date Title
BR9703884A (pt) Cicloalcanopiridinas
BR9704464A (pt) Evisceradora
BR9711066A (pt) Arilacanoilpiridazinas
BR9707851A (pt) Quinoxalinodionas
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
BR9703563A (pt) Hidromancal
BR9703835A (pt) Hidromancal
BR9707467A (pt) 1-Pirazol-3-iletil-4-indol-3-ilpiperdinas
BR9708716A (pt) 3-cianoaril-pirazóis
DE29602607U1 (de) Bitbox
DE29603135U1 (de) Strähnen-Blondier-Färbe-Klammer
DE29606875U1 (de) Schraubenzieher - Hilfe
ATE267568T1 (de) Epithese
BR9603976A (pt) Stop-entope
BR9600914A (pt) Lipodecantador
FI964164A (fi) Taimisuojus
BR9606252A (pt) Cromosauna
BR9606119A (pt) Heliceboy
BR9605529A (pt) Banzo
BR9605291A (pt) Hidro-coleta
BR9604479A (pt) Gongorremo
BR9604349A (pt) Xapisqueira
BR9603978A (pt) Confort-let
BR9603977A (pt) Fix-ped
BR7600260U (pt) Multi-morsa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application